SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,957.27 -307.24
( -0.40%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.8

4102.06

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Back

Gufic BioSciences consolidated net profit rises 70.70% in the June 2026 quarter

Aug 15,2026

Net profit of Gufic BioSciences rose 70.70% to Rs 22.31 crore in the quarter ended June 2026 as against Rs 13.07 crore during the previous quarter ended June 2025. Sales rose 16.58% to Rs 260.82 crore in the quarter ended June 2026 as against Rs 223.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	260.82	223.72	17
OPM %	17.87	14.88	-
PBDT	37.75	24.99	51
PBT	30.04	17.27	74
NP	22.31	13.07	71

76,957.27 -307.24 ( -0.40%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)